Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 4
2005 6
2006 6
2007 9
2008 4
2009 8
2010 7
2011 5
2012 7
2013 9
2014 6
2015 7
2016 6
2017 14
2018 11
2019 8
2020 19
2021 21
2022 14
2023 10

Text availability

Article attribute

Article type

Publication date

Search Results

161 results

Results by year

Filters applied: . Clear all
Page 1
Extracellular matrix-based cancer targeting.
Karamanos NK, Piperigkou Z, Passi A, Götte M, Rousselle P, Vlodavsky I. Karamanos NK, et al. Among authors: gotte m. Trends Mol Med. 2021 Oct;27(10):1000-1013. doi: 10.1016/j.molmed.2021.07.009. Epub 2021 Aug 10. Trends Mol Med. 2021. PMID: 34389240 Review.
Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.
Ibrahim SA, Gadalla R, El-Ghonaimy EA, Samir O, Mohamed HT, Hassan H, Greve B, El-Shinawi M, Mohamed MM, Götte M. Ibrahim SA, et al. Among authors: gotte m. Mol Cancer. 2017 Mar 7;16(1):57. doi: 10.1186/s12943-017-0621-z. Mol Cancer. 2017. PMID: 28270211 Free PMC article.
Editorial: Molecules of the extracellular matrix as cancer targets.
Karamanos NK, Götte M, Passi A. Karamanos NK, et al. Among authors: gotte m. Front Oncol. 2022 Sep 20;12:1034646. doi: 10.3389/fonc.2022.1034646. eCollection 2022. Front Oncol. 2022. PMID: 36203416 Free PMC article. No abstract available.
Cellular microenvironment in human pathologies.
Vigetti D, Götte M, Pavão MS, Theocharis AD. Vigetti D, et al. Among authors: gotte m. Biomed Res Int. 2013;2013:946958. doi: 10.1155/2013/946958. Epub 2013 Nov 7. Biomed Res Int. 2013. PMID: 24312914 Free PMC article. No abstract available.
Role of syndecan-4 in breast cancer pathophysiology.
Onyeisi JOS, Lopes CC, Götte M. Onyeisi JOS, et al. Among authors: gotte m. Am J Physiol Cell Physiol. 2022 Nov 1;323(5):C1345-C1354. doi: 10.1152/ajpcell.00152.2022. Epub 2022 Sep 12. Am J Physiol Cell Physiol. 2022. PMID: 36094435 Review.
Extracellular matrix functions in lung cancer.
Götte M, Kovalszky I. Götte M, et al. Matrix Biol. 2018 Nov;73:105-121. doi: 10.1016/j.matbio.2018.02.018. Epub 2018 Feb 27. Matrix Biol. 2018. PMID: 29499357 Review. No abstract available.
miRNAs in the Era of Personalized Medicine: From Biomarkers to Therapeutics.
Mc Cormack BA, González-Cantó E, Agababyan C, Espinoza-Sánchez NA, Tomás-Pérez S, Llueca A, Marí-Alexandre J, Götte M, Gilabert-Estellés J. Mc Cormack BA, et al. Among authors: gotte m. Int J Mol Sci. 2021 Jul 29;22(15):8154. doi: 10.3390/ijms22158154. Int J Mol Sci. 2021. PMID: 34360918 Free PMC article.
Proteoglycan Expression Studied by MicroRNAs.
Espinoza-Sanchez NA, Troschel F, Greve B, Götte M. Espinoza-Sanchez NA, et al. Among authors: gotte m. Methods Mol Biol. 2023;2619:273-292. doi: 10.1007/978-1-0716-2946-8_20. Methods Mol Biol. 2023. PMID: 36662477
161 results